参考文献/References:
[1]Saeedi P,Petersohn I,Salpea P,et al.Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition[J].Diabetes Res Clin Pract,2019,157:107843.
[2]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].中华糖尿病杂志,2021,13(4):315-409.
[3]张琦,乔小娜,伊娜,等.皮肤自发荧光(SAF)与中国2型糖尿病患者周围神经病变(DPN)的相关性[J].复旦学报(医学版),2019,46(3):316-323.
[4]吴立,崔艳丽,路丽,等.女性代谢异常与围绝经期的关系探讨[J].中国药物与临床,2021,21(3):420-422.
[5]吴斌.围绝经期女性血清性激素水平与血脂四项的相关性[J].中国妇幼保健,2021,36(3):669-671.
[6]Razmjou S,Abdulnour J,Bastard JP,et al.Body composition, cardiometabolic risk factors, physical activity, and inflammatory markers in premenopausal women after a 10-year follow-up: a MONET study[J].Menopause,2018,25(1):89-97.
[7]Sliwińska-Mossoń M,Milnerowicz H.The impact of smoking on the development of diabetes and its complications[J].Diab Vasc Dis Res,2017,14(4):265-276.
[8]李茂全.糖尿病足介入综合诊治临床指南(第六版)[J].介入放射学杂志,2020,29(9):853-866.
[9]Volmer-Thole M,Lobmann R.Neuropathy and Diabetic Foot Syndrome[J].Int J Mol Sci,2016,17(6):917.
[10]魏文静,陈秋.黄芪桂枝五物汤治疗糖尿病周围神经病变的研究概况[J].广西中医药大学学报,2020,23(3):73-75.
[11]魏易琼,苏常春,周倩,等.神经传导、F波及皮肤交感反应联合检测对糖尿病周围神经病变早期诊断的价值[J].华中科技大学学报(医学版),2020,49(4):477-480.
[12]中国中西医结合学会周围血管病专业委员会.中西医结合防治糖尿病足中国专家共识(第1版)[J].血管与腔内血管外科杂志,2019,5(5):379-402.
[13]Alonso-Morán E,Orueta JF,Fraile Esteban JI,et al.The prevalence of diabetes-related complications and multimorbidity in the population with type 2 diabetes mellitus in the Basque Country[J].BMC Public Health,2014,14:1059.
[14]雷远,陶睿,王佑民.不同年龄层次糖尿病患者并发周围神经病变的危险因素比较[J].神经损伤与功能重建,2020,15(8):453-456.
[15]Mao F,Zhu X,Liu S,et al.Age as an Independent Risk Factor for Diabetic Peripheral Neuropathy in Chinese Patients with Type 2 Diabetes[J].Aging Dis,2019,10(3):592-600.
[16]Naqvi SSZH,Imani S,Hosseinifard H,et al.Associations of serum low-density lipoprotein and systolic blood pressure levels with type 2 diabetic patients with and without peripheral neuropathy: systemic review, meta-analysis and meta-regression analysis of observational studies[J].BMC Endocr Disord,2019,19(1):125.
[17]魏薇,王中京,周玲,等.2型糖尿病周围神经病变的危险因素分析[J].海南医学,2017,28(20):3379-3381.
[18]Zhang Y,Jiang Y,Shen X,et al.Can both normal and mildly abnormal albuminuria and glomerular filtration rate be a danger signal for diabetic peripheral neuropathy in type 2 diabetes mellitus? [J].Neurol Sci,2017,38(8):1381-1390.
相似文献/References:
[1]黄德斌,章臻翊,章 婷,等.2型糖尿病患者亚临床甲状腺功能减退与白蛋白尿的关系研究[J].医学信息,2018,31(02):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
HUANG De-bin,ZHANG Zhen-yi,ZHANG Ting,et al.Relationship between Subclinical Hypothyroidism and Albuminuria in
Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(21):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
[2]邓婷婷,王亚洲,张 红.口福怡稻治疗2型糖尿病的临床效果研究[J].医学信息,2018,31(03):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
DENG Ting-ting,WANG Ya-zhou,ZHANG Hong.Clinical Study on the Treatment of Type 2 Diabetes Mellitus with Kou Fuyi Dao[J].Journal of Medical Information,2018,31(21):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
[3]曹岚,侯瑞田,王福慧,等.Lp-PLA2血小板相关因子与2型糖尿病合并高血压病的
相关性研究[J].医学信息,2018,31(05):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
CAO Lan,HOU Rui-tian,WANG Fu-hui,et al.Study on the Correlation between Lp-PLA2 Platelet-associated Factors and Type 2 Diabetes Mellitus Complicated with Hypertension[J].Journal of Medical Information,2018,31(21):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
[4]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Journal of Medical Information,2018,31(21):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[5]刘 洪.地特胰岛素或甘精胰岛素联合使用口服药物治疗2型糖尿病疗效及对体重的影响分析[J].医学信息,2018,31(09):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
LIU Hong.Effect of Insulin Detemir or Insulin Glargine Combined with Oral Medication on Type 2 Diabetes Mellitus and its Influence on Body Weight[J].Journal of Medical Information,2018,31(21):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
[6]郭云飞,王亚柱,刘 超,等.血浆致动脉硬化指数与冠心病合并2型糖尿病的相关性分析[J].医学信息,2022,35(09):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
GUO Yun-fei,WANG Ya-zhu,LIU Chao,et al.Correlation Between Plasma Arteriosclerosis Index and Coronary Heart Disease Complicated with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2022,35(21):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
[7]徐晨曦.达格列净联合DPP-4抑制剂与二甲双胍对血糖控制不佳2型糖尿病患者血糖及脂代谢的影响[J].医学信息,2022,35(09):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
XU Chen-xi.Effects of Daglitazone Combined with DPP-4 Inhibitor and Metformin on Blood Glucose and Lipid Metabolism in Patients with Type 2 Diabetes Mellitus with Poor Glycemic Control[J].Journal of Medical Information,2022,35(21):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
[8]余 佳.早期胰岛素强化治疗对初诊2型糖尿病患者血糖控制效果及颈动脉粥样硬化进展的影响[J].医学信息,2022,35(10):140.[doi:10.3969/j.issn.1006-1959.2022.10.034]
YU Jia.Effect of Early Intensive Insulin Therapy on Blood Glucose Control and Progression of Carotid Atherosclerosis in Newly Diagnosed Type 2 Diabetic Mellitus Patients[J].Journal of Medical Information,2022,35(21):140.[doi:10.3969/j.issn.1006-1959.2022.10.034]
[9]张剑君.2型糖尿病参与血管衰老的机制[J].医学信息,2022,35(11):37.[doi:10.3969/j.issn.1006-1959.2022.11.011]
ZHANG Jian-jun.The Mechanism of Type 2 Diabetes Mellitus in Vascular Aging[J].Journal of Medical Information,2022,35(21):37.[doi:10.3969/j.issn.1006-1959.2022.11.011]
[10]刘静波,黄 萍,赵 静.应用微信平台对初发中青年2型糖尿病患者进行
健康管理模式的研究[J].医学信息,2018,31(14):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
LIU Jing-bo,HUANG Ping,ZHAO Jing.Study on the Health Management Model of Young and Middle-aged Patients with Type 2 Diabetes Mellitus by WeChat Platform[J].Journal of Medical Information,2018,31(21):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]